Sky-high OxyContin sales are threatened by reports of abuse, prosecutors investigate a claim central to OxyContin marketing, and Finnix begins to question the safety of the drug.
59:07 → 1:01:19.1 (3547s–3679.1s)
skips 132.1s · timed on a 1:01:19.1 stream
Submitted Aug 19, 2026
Times accept seconds (91) or clock format (1:31).
